{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:15:00Z","timestamp":1789172100478,"version":"build-2803163510"},"reference-count":40,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Once\u2010weekly basal insulins, icodec and efsitora alfa, were developed to improve treatment adherence and glycemic control and appear to be as effective as once\u2010daily degludec in reducing HbA1c in type 1 diabetes (T1DM). However, higher rates of clinically significant hypoglycemias were associated with both once\u2010weekly insulins. This network meta\u2010analysis compares the efficacy and safety of once\u2010weekly and once\u2010daily basal insulins in T1DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed and Embase were searched (up to April, 2025) to identify phase 3 clinical trials evaluating basal insulins in T1DM (icodec, efsitora alfa, degludec 100, glargine [100 and 300], detemir, and NPH). Change in HbA1c and weight, risk of hypoglycemias (overall and severe), and serious adverse events (AEs) were assessed at week 26 and 52.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nineteen studies were included. At week 52, icodec reduced HbA1c more than degludec 100 (\u22120.17% [95% CrI: \u22120.28; \u22120.06]), glargine 100 (\u22120.17% [95% CrI: \u22120.32; \u22120.02]), detemir (\u22120.17% [95% CrI: \u22120.32; \u22120.02]), and NPH (\u22120.59% [95% CrI: \u22120.85; \u22120.34]), while efsitora alfa reduced HbA1c more than NPH (\u22120.45% [95% CrI: \u22120.70; \u22120.19]). Icodec showed a higher overall hypoglycemia risk at week 52 compared with degludec 100 (OR 1.64; 95% CrI 1.07\u20132.54) and detemir (OR 2.08; 95% CrI 1.01\u20134.39), but no increased risk of severe hypoglycemias or serious AEs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In T1DM, once\u2010weekly basal insulins appear broadly comparable in reducing HbA1c at week 52. Although icodec showed a higher overall hypoglycemia risk, evidence suggests a comparable risk of severe hypoglycemias between treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70905","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:35:16Z","timestamp":1780360516000},"page":"7227-7236","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Once\u2010Weekly and Once\u2010Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta\u2010Analysis of Clinical Trials"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6085-8388","authenticated-orcid":false,"given":"Ricardo","family":"Amaral","sequence":"first","affiliation":[{"name":"Clevidence, Lda  Oeiras Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1469-8865","authenticated-orcid":false,"given":"Beatriz","family":"Costa","sequence":"additional","affiliation":[{"name":"Clevidence, Lda  Oeiras Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2061-4718","authenticated-orcid":false,"given":"Ana","family":"Penedones","sequence":"additional","affiliation":[{"name":"Clevidence, Lda  Oeiras Portugal"},{"name":"Laboratory of Social Pharmacy and Public Health, Faculty of Pharmacy University of Coimbra  Coimbra Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-8717","authenticated-orcid":false,"given":"Diogo","family":"Mendes","sequence":"additional","affiliation":[{"name":"Clevidence, Lda  Oeiras Portugal"},{"name":"Laboratory of Social Pharmacy and Public Health, Faculty of Pharmacy University of Coimbra  Coimbra Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-3049","authenticated-orcid":false,"given":"Carlos","family":"Alves","sequence":"additional","affiliation":[{"name":"Clevidence, Lda  Oeiras Portugal"},{"name":"Laboratory of Social Pharmacy and Public Health, Faculty of Pharmacy University of Coimbra  Coimbra Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(13)60591\u20107"},{"key":"e_1_2_9_3_1","unstructured":"\u201cType 1 Diabetes\u2010Statpearls\u2010NCBI Bookshelf \u201daccessed November 5 2025 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507713\/."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(22)00218\u20102"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/DCI21\u20100043"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(23)02179\u20107"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(24)01804\u2010X"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/EDM2.70048"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/DOM.70176"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2024.1459127"},{"key":"e_1_2_9_11_1","unstructured":"University of York C for R and D \u201cSystematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care \u201daccessed November 6 2025 https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14\u20102385"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.L4898"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.1003082"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1080"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008929526011\/METRICS"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118951651.ch2"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467\u20109868.00353"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1464\u20105491.2007.02407.X"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(12)60204\u20109"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/DOM.12298"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/DOM.12573"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2012\u20103249"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2008.05.003"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1463\u20101326.2004.00363.X"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2337\/DC15\u20100249"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/DOM.13048"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1445\u20105994.2005.00902.X"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.10.006"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP.10.1.10"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/DMRR.572"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1464\u20105491.2007.02113.X"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1464\u20105491.2004.01323.X"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149\u20102918(04)90072\u20100"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/DIA.2004.6.579"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/DIACARE.26.3.590"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110238"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/JRSM.1411"},{"key":"e_1_2_9_39_1","unstructured":"\u201cType 2 Diabetes in Adults: Management NICE Guideline \u201d 2015 accessed January 9 2026 www.nice.org.uk\/guidance\/ng28."},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJDRC\u20102021\u2010002301"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1210\/ENDREV\/BNAD037"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70905","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.70905","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:44:48Z","timestamp":1789170288000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.70905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/dom.70905"],"URL":"https:\/\/doi.org\/10.1111\/dom.70905","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"2025-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}